Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

ATRC vs KTWO: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ATRC Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 6–3 Matrix Metrics)

ATRC Overall Winner 6-Pillar Tally: ATRC 5 – 0 KTWO (1 Tie) Matrix Metrics: ATRC 6 – 3 KTWO

As of Nov 20, 2026, AtriCure, Inc. (ATRC) is the stronger overall head-to-head candidate over KTWO (KTWO) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ATRC carries a Unified Composite Score of 53.7/100 (HOLD) at $55.39 (122.1x Forward P/E, 2.9% operating margin), whereas KTWO carries 55.8/100 (HOLD) at $10.12 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While KTWO currently prints a higher short-term Unified Composite Score (55.8/100 HOLD vs. ATRC 53.7/100 HOLD), ATRC captures the overall institutional head-to-head verdict (6–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (2.9% vs. N/A operating margin) and revenue trajectory (+15.0% vs. N/A YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ATRC vs KTWO
ATRC NASDAQ Head-to-Head Winner
AtriCure, Inc.
Surgical & Medical Instruments & Apparatus
$55.39
+2.37% 1D
Market Cap $2.8B
TTM Revenue $590M
Forward P/E 122.1x
Beta / 30D Vol 0.47β · 49% Vol
Unified Composite Score
53.7 / 100 HOLD
Tech 42.0 Fund 47.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 44.8 · SMA20: $58.65 · SMA50: $57.67
KTWO US Equity
KTWO
Institutional Equity
$10.12
-0.1% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.02β · 4% Vol
Unified Composite Score
55.8 / 100 HOLD
Tech 66.0 Fund 57.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 57
RSI-14: 57.0 · SMA20: $9.96 · SMA50: $9.96

6-Pillar Scorecard Institutional Category Breakdown (ATRC 5 – 0 KTWO)

Columns: Metric · ATRC · KTWO
1. Valuation Multiples ATRC
Forward P/E 122.1x N/M
Trailing P/E N/M N/M
PEG Ratio 10.00x N/M
EV / Revenue 4.7x N/M
2. Growth & Scale ATRC
Revenue Growth (YoY) +15.0% N/A
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) $590M N/A
Market Cap $2.8B N/A
3. Profitability & Quality ATRC
Gross Margin 76.7% N/A
Operating Margin 2.9% N/A
Net Profit Margin 2.5% N/A
Return on Equity (ROE) 2.9% N/A
4. Balance Sheet & Cash Flow ATRC
Cash Generation (TTM) $38M EBITDA N/A
Cash Flow Margin 6.5% EBITDA Mgn N/A
Net Cash / Leverage $10.47 Book/Sh · 2.9% ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 44.5% (74th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat ATRC
OpEx & R&D Intensity 73.8% of Rev ($435M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Instruments & Supplies Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ATRC (6) vs KTWO (3)
Institutional Metric ATRC KTWO Criterion Row Edge
Market Capitalization
Scale
$2.8B N/A Larger Scale ATRC
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
122.1x N/M Lower Multiple ATRC
Revenue Growth (YoY)
Growth
+15.0% N/A Higher Growth ATRC
Operating Margin (TTM)
Profitability
2.9% N/A Higher Margin ATRC
Net Profit Margin
Profitability
2.5% N/A Higher Margin ATRC
Return on Equity (ROE)
Capital Efficiency
2.9% N/A Higher ROE ATRC
52-Week Range Position
Momentum
74% ($25–$66) 97% ($10–$10) Stronger Trend KTWO
Beta / 30D Volatility
Risk Regime
0.47β · 49% Vol 0.02β · 4% Vol Lower Realized Risk KTWO
Unified Institutional Score
Composite Signal
53.7 / 100 (HOLD) 55.8 / 100 (HOLD) Higher Composite KTWO
Trailing 12M Revenue (USD)
Operating Scale
$590M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
76.7% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
10.00x PEG · 4.7x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$38M EBITDA ($10.47 Book/Sh · 2.9% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ATRC +0.77 pp
ATRC: +0.97% · KTWO: +0.2%
3M Horizon ATRC +104.82 pp
ATRC: +106.53% · KTWO: +1.71%
6M Horizon ATRC +70.96 pp
ATRC: +73.49% · KTWO: +2.53%
1Y Horizon ATRC +70.96 pp
ATRC: +73.49% · KTWO: +2.53%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ATRC vs KTWO. Trailing 12-month operating profitability (ATRC 2.9% vs KTWO N/A) and valuation multiples (ATRC 122.1x vs KTWO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ATRC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$590M
Gross Margin76.7%
Op. Margin2.9%
ROE / Fwd P/E2.9% · 122.1x
KTWO ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ATRC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 44.5%
IV Percentile 74th %ile
Put/Call OI Skew N/A
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ATRC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
KTWO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KTWO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ATRC Moat Profile Cyclical / Execution-Driven Positioning
Medical Instruments & Supplies Operator
Competes within the Medical Instruments & Supplies value chain with $2.8B market capitalization and 2.9% operating margin.
OpEx & R&D Reinvestment 73.8% of Rev ($435M)
90D Engineering Disclosures 0 Published
KTWO Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ATRC vs KTWO Key Questions & Quantitative Answers

As of Nov 20, 2026, AtriCure, Inc. (ATRC) is the stronger overall head-to-head candidate over KTWO (KTWO) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ATRC carries a Unified Composite Score of 53.7/100 (HOLD) at $55.39 (122.1x Forward P/E, 2.9% operating margin), whereas KTWO carries 55.8/100 (HOLD) at $10.12 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While KTWO currently prints a higher short-term Unified Composite Score (55.8/100 HOLD vs. ATRC 53.7/100 HOLD), ATRC captures the overall institutional head-to-head verdict (6–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (2.9% vs. N/A operating margin) and revenue trajectory (+15.0% vs. N/A YoY).

ATRC leads the Growth & Scale pillar: ATRC posts +15.0% YoY revenue growth and +0.0% YoY earnings growth on $590M TTM revenue (76.7% gross margin, 2.9% operating margin), compared with KTWO at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, ATRC generates $590M in USD-normalized revenue versus N/A for KTWO. In operating R&D and SG&A reinvestment, ATRC deploys 73.8% of Rev ($435M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for KTWO.

ATRC screens cheaper on headline valuation multiples. ATRC trades at 122.1x Forward P/E, N/M Trailing P/E, 10.00x PEG, and 4.7x EV/Revenue (6.5% EBITDA margin), whereas KTWO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ATRC (2.9% ROE) versus KTWO (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, ATRC carries 44.5% implied volatility (74th %ile, Elevated (60th–80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.47β · 49% Vol realized risk). By comparison, KTWO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 4% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.